Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models.

Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models. World J Gastroenterol. 2018 Mar 28; 24(12):1321-1331.

View in: PubMed

subject areas

Biomarkers, Tumor
Carcinoma, Hepatocellular
Female
Follow-Up Studies
Humans
Liver Neoplasms
Liver Transplantation
Male
Middle Aged
Models, Biological
Neoplasm Recurrence, Local
Prognosis
Proportional Hazards Models
Retrospective Studies
Severity of Illness Index
Treatment Outcome

authors with profiles

Michael Charlton